Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Successful correction of metabolic acidosis is difficult to achieve inchronic kidney disease
Fernando Caravaca-Fontán; Rosa Díaz-Campillejo; Julián Valladares; Cristina López Arnaldo; Sergio Barroso; Enrique Luna; Francisco Caravaca;
Nefrologia (English Version). 2020;40:328-35
Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies
William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;
Nefrologia (English Version). 2024;44:796-806
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;
Nefrologia (English Version). 2023;43 Supl 1:1-36